PEP vs TGTX · P/E 22, rev $43.62B vs P/E 18, rev $240.3M
PepsiCo Inc (PEP) versus TG Therapeutics Inc (TGTX) — a side-by-side from cached financials, not a winner call.
PepsiCo Inc (PEP) is a beverages - non-alcoholic company listed on NASDAQ. It is led by Ramon Luis Laguarta.
TG Therapeutics Inc (TGTX) is a biotechnology company listed on NASDAQ.
Latest reported PEP revenue for 2026-06-13 was $43.62B. Net income was $5.31B. PEP currently screens at market cap $193.55B and trailing P/E 22.2.
Latest reported TGTX revenue for 2026-06-30 was $240.3M. Net income was $7.8M. Revenue was up 17.3% from 2026-03-31 to 2026-06-30. TGTX currently screens at market cap $7.88B and trailing P/E 18.0.
PEP currently screens at market cap $193.55B and trailing P/E 22.2. TGTX currently screens at market cap $7.88B and trailing P/E 18.0.
Not investment advice. Open the PEP and TGTX stock pages for the full models.
Not investment advice.